SygnaMap
SygnaMap applies spatial omics and AI-driven pathology to identify disease signatures for precision medicine. Its MSI-DeepPath computational platform quantifies spatial metabolite patterns with histopathologic features. The company develops precision diagnostics and therapeutics for complex diseases, including rare and common conditions. Core technologies include Spatial Omics, AI, Computational Imaging, Computational Pathology and Mass Spectrometry. Based in San Antonio, it serves biotech and pharmaceutical companies seeking targeted, patient-specific therapies.
SygnaMap
SygnaMap applies spatial omics and AI-driven pathology to identify disease signatures for precision medicine. Its MSI-DeepPath computational platform quantifies spatial metabolite patterns with histopathologic features. The company develops precision diagnostics and therapeutics for complex diseases, including rare and common conditions. Core technologies include Spatial Omics, AI, Computational Imaging, Computational Pathology and Mass Spectrometry. Based in San Antonio, it serves biotech and pharmaceutical companies seeking targeted, patient-specific therapies.